MAKAYLA BOGARD: Open Payments
NPI 1972257681 · OLNEY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 29 payments from 6 companies in 2025. Trend: 2023 $323 · 2024 $598 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $249 |
| Novartis Pharmaceuticals Corporation | 5 | $111 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| Amgen Inc. | 5 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $57 |
| Boston Scientific Corporation | 1 | $30 |
Products named: VERQUVO, LEQVIO, FARXIGA, REPATHA, JARDIANCE, WATCHMAN Access System, CAPVAXIVE.
Industry payments across IL — which companies pay providers there.
